skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
WT1 Peptide Vaccine OCV-501 (Code C106257)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: WT1 Peptide Vaccine OCV-501

Definition: A peptide cancer vaccine comprised of a peptide derived from Wilms tumor gene 1 (WT1) protein, with potential immunomodulating and antineoplastic activities. Upon subcutaneous administration, WT1 peptide vaccine OCV-501 may stimulate a CD4-positive helper T-lymphocyte-mediated immune response against WT1 expressing cells. WT1 protein, a zinc finger DNA-binding protein, is overexpressed in leukemic cells and in some solid tumors.

Label: WT1 Peptide Vaccine OCV-501

NCI Thesaurus Code: C106257 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL433890  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
WT1 Peptide Vaccine OCV-501

External Source Codes: 
PDQ Closed Trial Search ID 713831
PDQ Open Trial Search ID 713831 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C106257
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom